/PRNewswire/ KAHR, a clinical-stage biotech company developing a novel, bi-specific CD47x4-1BB targeting immunotherapy that activates innate and adaptive.
В Калининградской области ужесточили ограничения из-за COVID-19 rg.ru - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from rg.ru Daily Mail and Mail on Sunday newspapers.
KAHR Announces $46.5 Million Financing to Advance its Multifunctional Immunotherapeutic Pipeline prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
Israeli cancer drug developer KAHR raises $46.5m globes.co.il - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globes.co.il Daily Mail and Mail on Sunday newspapers.
Immunotherapy startup KAHR gets $46.5 million from investors timesofisrael.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from timesofisrael.com Daily Mail and Mail on Sunday newspapers.